Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.63 - $1.14 $100,783 - $182,370
-159,974 Reduced 92.6%
12,784 $10,000
Q2 2023

Aug 14, 2023

SELL
$1.31 - $2.04 $381,993 - $594,859
-291,598 Reduced 62.8%
172,758 $276,000
Q1 2023

May 15, 2023

BUY
$1.45 - $2.95 $406,648 - $827,318
280,447 Added 152.49%
464,356 $705,000
Q4 2022

Feb 14, 2023

SELL
$2.02 - $3.25 $225,264 - $362,430
-111,517 Reduced 37.75%
183,909 $441,000
Q3 2022

Nov 14, 2022

BUY
$1.96 - $3.14 $579,034 - $927,637
295,426 New
295,426 $606,000
Q2 2022

Aug 15, 2022

SELL
$1.3 - $2.64 $61,436 - $124,763
-47,259 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$2.35 - $3.47 $70,803 - $104,547
30,129 Added 175.88%
47,259 $116,000
Q4 2021

Feb 14, 2022

BUY
$2.92 - $5.74 $50,019 - $98,326
17,130 New
17,130 $55,000
Q3 2021

Nov 15, 2021

SELL
$4.98 - $6.63 $2.01 Million - $2.67 Million
-402,992 Closed
0 $0
Q2 2021

Aug 16, 2021

BUY
$2.56 - $5.49 $383,390 - $822,193
149,762 Added 59.14%
402,992 $2.21 Million
Q1 2021

May 17, 2021

BUY
$2.69 - $5.25 $32,570 - $63,567
12,108 Added 5.02%
253,230 $689,000
Q4 2020

Feb 16, 2021

BUY
$3.17 - $4.49 $313,221 - $443,647
98,808 Added 69.43%
241,122 $767,000
Q3 2020

Nov 16, 2020

BUY
$2.98 - $5.2 $319,599 - $557,689
107,248 Added 305.85%
142,314 $569,000
Q2 2020

Aug 14, 2020

SELL
$2.29 - $4.24 $14,605 - $27,042
-6,378 Reduced 15.39%
35,066 $138,000
Q1 2020

May 15, 2020

SELL
$1.92 - $4.39 $678,504 - $1.55 Million
-353,388 Reduced 89.5%
41,444 $102,000
Q4 2019

Feb 14, 2020

BUY
$2.41 - $4.4 $951,545 - $1.74 Million
394,832 New
394,832 $1.61 Million
Q3 2019

Nov 14, 2019

SELL
$2.17 - $3.14 $192,958 - $279,211
-88,921 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$2.53 - $3.04 $170,656 - $205,057
67,453 Added 314.2%
88,921 $267,000
Q1 2019

May 15, 2019

SELL
$2.51 - $3.73 $3,109 - $4,621
-1,239 Reduced 5.46%
21,468 $64,000
Q4 2018

Feb 14, 2019

BUY
$1.59 - $2.66 $270 - $452
170 Added 0.75%
22,707 $54,000
Q3 2018

Nov 14, 2018

SELL
$1.59 - $2.42 $74,844 - $113,914
-47,072 Reduced 67.62%
22,537 $48,000
Q2 2018

Aug 14, 2018

BUY
$2.26 - $4.65 $132,467 - $272,555
58,614 Added 533.1%
69,609 $158,000
Q1 2018

May 15, 2018

SELL
$3.51 - $6.04 $102,502 - $176,386
-29,203 Reduced 72.65%
10,995 $52,000
Q4 2017

Feb 14, 2018

BUY
$3.26 - $4.78 $36,084 - $52,909
11,069 Added 38.0%
40,198 $131,000
Q3 2017

Nov 14, 2017

BUY
$3.48 - $4.44 $101,368 - $129,332
29,129
29,129 $128,000

Others Institutions Holding AGEN

About AGENUS INC


  • Ticker AGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 283,163,008
  • Market Cap $4.73B
  • Description
  • Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...
More about AGEN
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.